{"organizations": [], "uuid": "d23e0600edb00565ae5b1310474a715852df36cf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180123.html", "section_title": "Archive News &amp; Video for Tuesday, 23 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-taiwan-leader-biotech-gets-tfda-ap/brief-taiwan-leader-biotech-gets-tfda-approval-for-clinical-trial-of-botanical-drug-leac-102-in-taiwan-idUSL4N1PI4FG", "country": "US", "domain_rank": 408, "title": "BRIEF-Taiwan Leader Biotech gets TFDA approval for clinical trial of botanical drug LEAC-102 in Taiwan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.046, "site_type": "news", "published": "2018-01-23T19:51:00.000+02:00", "replies_count": 0, "uuid": "d23e0600edb00565ae5b1310474a715852df36cf"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-taiwan-leader-biotech-gets-tfda-ap/brief-taiwan-leader-biotech-gets-tfda-approval-for-clinical-trial-of-botanical-drug-leac-102-in-taiwan-idUSL4N1PI4FG", "ord_in_thread": 0, "title": "BRIEF-Taiwan Leader Biotech gets TFDA approval for clinical trial of botanical drug LEAC-102 in Taiwan", "locations": [], "entities": {"persons": [], "locations": [{"name": "taiwan", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "tfda", "sentiment": "negative"}, {"name": "taiwan leader biotech corp", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 23 (Reuters) - Taiwan Leader Biotech Corp :\n* Says it gets TFDA approval for clinical trial of botanical drug LEAC-102 in Taiwan\n* LEAC-102 is used for adjunctive therapy of colorectal cancer\n* The clinical trial will start up in May\nSource text in Chinese: goo.gl/1t63QG\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/1t63QG", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-23T19:51:00.000+02:00", "crawled": "2018-01-24T15:41:34.003+02:00", "highlightTitle": ""}